Abstract
C14H15N1O4, triclinic, P1̄, a = 8.2018(4) Å, b = 11.5512(5) Å, c = 14.4121(7) Å, α = 79.242(2)°, β = 78.647(3)°, γ = 85.496(3)°, V = 1313.93(11) Å3, Z = 2, Rgt(F) = 0.0548, wRref(F2) = 0.1805, T = 296(2) K.
The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Crystal: | Colorless block |
Size: | 0.26 × 0.24 × 0.18 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 0.10 mm−1 |
Diffractometer, scan mode: | Bruker APEX-II, φ and ω |
θmax, completeness: | 27.6°, 99% |
N(hkl)measured, N(hkl)unique, Rint: | 20977, 5899, 0.017 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 3894 |
N(param)refined: | 347 |
Programs: | Bruker APEX system [1], SHELX [2, 3] |
Atom | x | y | z | Uiso*/Ueq |
---|---|---|---|---|
O7 | 0.82537(15) | 0.62219(10) | 0.75870(8) | 0.0605(3) |
O3 | 0.83969(15) | 0.43118(10) | 0.46707(9) | 0.0607(3) |
O4 | 0.71137(16) | 0.42066(10) | 0.61983(9) | 0.0638(3) |
O5 | 0.80262(16) | 0.91956(10) | 0.50978(8) | 0.0632(4) |
O6 | 0.64784(17) | 1.08640(10) | 0.51680(8) | 0.0691(4) |
O1 | 0.77740(18) | 0.70625(10) | 0.20914(8) | 0.0703(4) |
O8 | 0.71188(16) | 0.61463(11) | 0.91433(9) | 0.0684(4) |
O2 | 0.68179(19) | 0.89080(10) | 0.21902(9) | 0.0745(4) |
N1 | 0.49067(16) | 0.59313(10) | 0.66189(9) | 0.0503(3) |
H1 | 0.539924 | 0.527202 | 0.681547 | 0.060* |
N2 | 0.49905(17) | 0.79047(11) | 0.95934(9) | 0.0540(4) |
H2 | 0.546581 | 0.723685 | 0.978604 | 0.065* |
C18 | 0.69641(19) | 0.84022(12) | 0.70105(10) | 0.0451(3) |
H18 | 0.775211 | 0.799546 | 0.661877 | 0.054* |
C8 | 0.53875(19) | 0.63916(12) | 0.56918(11) | 0.0457(4) |
H8 | 0.490213 | 0.711800 | 0.546611 | 0.055* |
C6 | 0.73413(19) | 0.47397(13) | 0.53767(11) | 0.0481(4) |
C5 | 0.65401(19) | 0.58790(12) | 0.50454(11) | 0.0452(4) |
C22 | 0.54497(19) | 0.83624(13) | 0.86660(10) | 0.0476(4) |
H22 | 0.498156 | 0.909819 | 0.844825 | 0.057* |
C19 | 0.65539(19) | 0.78393(13) | 0.80070(11) | 0.0463(4) |
C20 | 0.7313(2) | 0.66769(13) | 0.83123(11) | 0.0495(4) |
C9 | 0.3710(2) | 0.63771(13) | 0.73128(11) | 0.0469(4) |
C4 | 0.69484(19) | 0.64128(12) | 0.40386(11) | 0.0475(4) |
H4 | 0.763220 | 0.595024 | 0.364360 | 0.057* |
C16 | 0.6924(2) | 0.99066(13) | 0.55655(11) | 0.0484(4) |
C23 | 0.3829(2) | 0.83753(13) | 1.02953(11) | 0.0486(4) |
C2 | 0.7012(2) | 0.79044(14) | 0.25783(11) | 0.0525(4) |
C17 | 0.6367(2) | 0.94246(13) | 0.65769(11) | 0.0524(4) |
H17 | 0.555412 | 0.985021 | 0.693859 | 0.063* |
C28 | 0.2854(2) | 0.93922(15) | 1.00824(12) | 0.0610(5) |
H28 | 0.294166 | 0.979222 | 0.945284 | 0.073* |
C10 | 0.3468(2) | 0.57444(15) | 0.82455(12) | 0.0585(4) |
H10 | 0.407962 | 0.504172 | 0.838282 | 0.070* |
C14 | 0.2781(2) | 0.74213(15) | 0.71127(12) | 0.0589(4) |
H14 | 0.291918 | 0.785525 | 0.649245 | 0.071* |
C24 | 0.3650(3) | 0.77924(16) | 1.12374(13) | 0.0654(5) |
H24 | 0.428938 | 0.710530 | 1.138385 | 0.078* |
C3 | 0.6484(2) | 0.74683(14) | 0.36010(11) | 0.0556(4) |
H3 | 0.578455 | 0.795488 | 0.396742 | 0.067* |
C11 | 0.2339(3) | 0.61424(16) | 0.89659(12) | 0.0671(5) |
H11 | 0.219312 | 0.571263 | 0.958773 | 0.080* |
C13 | 0.1650(3) | 0.78041(17) | 0.78491(13) | 0.0709(5) |
H13 | 0.102876 | 0.850376 | 0.771701 | 0.085* |
C27 | 0.1756(3) | 0.98000(16) | 1.08157(13) | 0.0704(5) |
H27 | 0.110535 | 1.048271 | 1.067512 | 0.085* |
C15 | 0.8677(3) | 0.96535(17) | 0.41106(12) | 0.0709(5) |
H15A | 0.777904 | 0.983005 | 0.376127 | 0.106* |
H15B | 0.943798 | 0.907734 | 0.383888 | 0.106* |
H15C | 0.925005 | 1.035972 | 0.407032 | 0.106* |
C12 | 0.1417(3) | 0.71829(18) | 0.87677(13) | 0.0714(5) |
H12 | 0.064800 | 0.745704 | 0.925300 | 0.086* |
C21 | 0.9084(3) | 0.50944(16) | 0.78300(15) | 0.0726(5) |
H21A | 0.970825 | 0.485415 | 0.725528 | 0.109* |
H21B | 0.827358 | 0.452171 | 0.814081 | 0.109* |
H21C | 0.982579 | 0.515446 | 0.825626 | 0.109* |
C7 | 0.9226(2) | 0.31916(15) | 0.49457(15) | 0.0702(5) |
H7A | 0.995494 | 0.297071 | 0.439310 | 0.105* |
H7B | 0.841264 | 0.260447 | 0.520203 | 0.105* |
H7C | 0.986218 | 0.325230 | 0.542548 | 0.105* |
C1 | 0.8426(3) | 0.74309(18) | 0.10951(12) | 0.0754(6) |
H1A | 0.875329 | 0.675029 | 0.079748 | 0.113* |
H1B | 0.937647 | 0.789687 | 0.102514 | 0.113* |
H1C | 0.758878 | 0.789366 | 0.079223 | 0.113* |
C26 | 0.1600(3) | 0.92208(17) | 1.17525(13) | 0.0720(5) |
H26 | 0.085824 | 0.951311 | 1.223952 | 0.086* |
C25 | 0.2547(3) | 0.82105(18) | 1.19600(12) | 0.0725(5) |
H25 | 0.244244 | 0.780778 | 1.258943 | 0.087* |
Source of material
Methyl propiolate (0.4203 g, 5.0 mmol), aniline (0.1863 g, 2.0 mmol), water (4 mL) and potassium sulfate (15.0 mg) were heated and stirred at 353 K for ten hours, then dichloromethane (15 mL) was added and the reaction mixture was poured into a separator funnel. The reaction mixture was concentrated by removing the solvent under vacuum, and the residue was purified by preparative TLC on silica, eluting with petroleum ether (333–363 K) : ethyl acetate (6:1,v/v) to give colourless block asymmetric unit of the title.
Experimental details
The non-methyl hydrogen atoms were identified in difference Fourier syntheses, but included using a riding model Uiso(H) = 1.2 Ueq(C). The methyl groups were idealized and refined using rigid groups allowed to rotate about the C—C bond (AFIX 137 option of the SHELXL-2015 program). There are two crystallogaphically independent molecules in the asymmetric unit. They show non-crystallographic (pseudo) translational symmetry. This phenomenon is known for small molecule structures as well as for biological systems [4] and my be checked by automated procedures [5].
Comment
Enyne compounds are not only important raw materials and intermediates in the organic synthesis, but also they are important building blocks for some anticancer drugs and antibiotics [6, 7] . The compounds having a conjugated alkenyl structure is known to have the strongest anticancer antibacterial activity at present [8, 9] . The synthesis and screening of reagents with high anticancer activity and stable low toxicity have become a research hotspot in chemistry, pharmacology, and molecular biology, especially the construction method of the conjugated alkyne structure of its core skeleton [10, 11] . Hence, there is considerable interest in the development of effective methods for the synthesis of it and its analogues [12, 13] .
However, the crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate has not been reported before. The title compound, built up by the C14H15N1O4 molecules, has been synthesized. The single-crystal structure verifies that all bond lengths and angles are in normal ranges.
The E, Z constitution was verified (cf. the figure).
Acknowledgements
The work was supported by the opening project of key laboratory of comprehensive utilization of advantage plants resources in Hunan south, Hunan university of science and engineering (XNZW17C07); The Planned Science and Technology Project of Hunan Province, China (NO. 2016GK3080) The project Study on New Drugs of Silybin Sustained-release Tablets (NO. 2017SK2204)
References
1. Bruker, SAINT, APEX and SADABS, Bruker Inc. Madison, WI, USA (2008).Search in Google Scholar
2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar
3. Sheldrick, G. M.: SHELXT-integrated space-group and crystal-structure determination. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053273314026370Search in Google Scholar
4. Zwart, P. H.; Grosse-Kunstleve, R. W.; Lebedev, A. A.; Murshudov, G. N.; Adams, P. D.: Surprises and pitfalls arising from (pseudo)symmetry. Acta Crystallogr. D 64 (2008) 99–107.10.1107/S090744490705531XSearch in Google Scholar
5. Spek, A. L.: What makes a crystal structure report valid? Inorg. Chim. Acta 470 (2018) 232–237.10.1016/j.ica.2017.04.036Search in Google Scholar
6. Nishiura, M.; Hou, Z. M.; Wakatauki, Y.: Novel Z-selective head-to-head dimerization of terminal alkynes catalyzed by lanthanide half metalpcene complexes. J. Am. Chem. Soc. 5 (2003) 1184–1185.10.1021/ja027595dSearch in Google Scholar
7. Nicolaou, K. C.; Dai, W. M.; Tsay, S. C.: Palladium-catalyzed dimerization of terminal alkynes. Science 256 (1992) 1172–1178.10.1126/science.256.5060.1172Search in Google Scholar
8. Grissom, J. W.; Gunawardena, G. U.; Klingderg, D.: The chemistry enediynes, enyne allenes and related compound. Tetrahedron 52 (1996) 6453–6518.10.1016/0040-4020(96)00016-6Search in Google Scholar
9. Lee, M. D.; Dunne, T. S.; Siegel, M. M.: Calichemicins, a novel family of antitumor antibiotics. Chemistry and partial structure of calichemicing. J. Am. Chem. Soc. 11 (1987) 3464–3465.10.1021/ja00245a050Search in Google Scholar
10. Golik, J.; Dubay, G.: Esperamicins, a novel class of potent antitumor antibiotics. J. Am. Chem. Soc. 11 (1987) 3461–3463.10.1021/ja00245a048Search in Google Scholar
11. Zhang, S. L.; Deng, Z. Q.: Synthesis of quinolines and naphthyridines via catalytic retro-aldol reaction of β–hydroxyketones with ortho-aminobenzaldehydes or nicotinaldehydes. Org. Biomol. Chem. 14 (2016) 8966–8970.10.1039/C6OB01452FSearch in Google Scholar PubMed
12. Chatterjee, M.; Gramer, K. D.; Townsend, C. A.: Nature of thiol activation in DNA cleavage by cali cheamicin. J. Am. Chem. Soc. 8 (1993) 3374–3375.10.1021/ja00061a064Search in Google Scholar
13. Zhang, X. Y.; Yuan, L.; Zhang, M.; Yuan, X. Y.: Crystal structure of (2-(4-bromophenyl)-5-ethyl-1,3-dioxan-5-yl)methanol, C13H17O3Br. Z. Kristallogr. NCS 213 (2016) 961–963.10.1515/ncrs-2016-0022Search in Google Scholar
©2018 Xiao-Ming Chen et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.